About KYAN Therapeutics

KYAN Therapeutics is a clinical-stage AI biotechnology company that utilizes proprietary technology to transform the way patients are treated and how therapies are developed. Our clinically-validated platforms revolutionize drug development by de-risking and dramatically accelerating the process at a fraction of the cost of traditional models.

Our Publications

Read more about the application of Optim.AI in various published peer-reviewed journals.

2020

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma
Experimental Hematology & Oncology

Artificial intelligence in cancer therapy
Science

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma
Blood Cancer Journal

2019

Harnessing Artificial Intelligence to Optimize Long‐Term Maintenance Dosing for Antiretroviral‐Naive Adults with HIV‐1 Infection
Advanced Therapeutics

Artificial Intelligence-Driven Designer Drug Combinations: From Drug Development to Personalized Medicine
SLAS Technology​

2018

Artificial Intelligence: Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform
Advanced Therapeutics

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)
Science Translational Medicine

2017

Optimizing Combination Therapy for Acute Lymphoblastic Leukemia Using a Phenotypic Personalized Medicine Digital Health Platform: Retrospective Optimization Individualizes Patient Regimens to Maximize Efficacy and Safety
SLAS Technology

2016

Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform
Science Translational Medicine

Diamonds, Digital Health, and Drug Development: Optimizing Combinatorial Nanomedicine
ACS Nano

Contact Us

Reach out to us now if you have interesting studies you would like to work with KYAN on or just to say hi!

Contact Us Now

Address

NUS Enterprise at 83 Science Park Drive, The Curie, #02-03/04, S118258 

Cell Phone

+65 9730 2672

Email

press@kyantherapeutics.com